User:M4c9s0/Dopaminergic pathways

From Wikipedia, the free encyclopedia

Article Draft[edit]

Lead[edit]

Dopaminergic pathways, sometimes called dopamine pathways or dopaminergic projections, are the sets of projection neurons in the brain that synthesize and release the neurotransmitter dopamine.[1][2] Individual neurons in these pathways are referred to as dopamine neurons. Dopamine neurons have axons that run the entire length of the pathway. The cell bodies of the neurons produce the enzymes that synthesize dopamine, and they are then transmitted via the projecting axons to their synaptic destinations, where most of the dopamine is produced. Dopaminergic nerve cell bodies in such areas as the substantia nigra pars compacta, where neurons are densely connected[3]tend to be pigmented due to the presence of the black pigment melanin, a direct chemical precursor to dopamine. Dopaminergic pathways are involved in many functions such as executive function, learning, reward, motivation, and neuroendocrine control.[4] Dysfunction of these pathways and nuclei may be involved in multiple diseases and disorders such as Parkinson's disease,[5] attention deficit hyperactivity disorder,[6] addiction,[7] and restless legs syndrome (RLS).[8] Copied from ((Dopaminergic pathways)).

Dopaminergic pathways, (dopamine pathways, dopaminergic projections) are comprised of individual dopamine neurons, which synthesize and release the neurotransmitter dopamine in the brain. .[1][2] The axons of the individual dopamine neurons run the entire length of the pathway (need citation).

Article body[edit]

Function[edit][edit]

The dopaminergic pathways that project from the substantia nigra pars compacta and ventral tegmental area into the striatum (i.e., the nigrostriatal and mesolimbic pathways, respectively) form one component of a sequence of pathways known as the cortico-basal ganglia-thalamo-cortical loop. The nigrostriatal component of the loop consists of the substantia nigra pars compacta (SNc), giving rise to both inhibitory and excitatory pathways that run from the striatum into the globus pallidus. The globus pallidus may directly connect to the thalamus or connect indirectly through subthalamic nucleus subthalamic nuclei.

Mesocorticolimbic pathways, as mentioned above in relation to the basal ganglia, are thought to mediate learning. Various models have been proposed, however the dominant one is that of temporal difference learning, in which a prediction is made before a reward and afterwards adjustment is made based on a learning factor and reward yield versus expectation leading to a learning curve.

The mesocortical pathway is primarily involved in the regulation of executive functions (e.g., attention, working memory, inhibitory control, planning, etc.), so it is particularly relevant to ADHD. The mesolimbic pathway regulates incentive salience, motivation, reinforcement learning, and fear, among other cognitive processes. The mesolimbic pathway is involved in motivation cognition. Depletion of dopamine in this pathway, or lesions at its site of origin, decrease the extent to which an animal is willing to go to obtain a reward (e.g., the number of lever presses for nicotine or time searching for food). Dopaminergic drugs are also able to increase the extent an animal is willing to go to get a reward, and the firing rate of neurons in the mesolimbic pathway increases during anticipation of reward. Mesolimbic dopamine release was once thought to be the primary mediator of pleasure, but is now believed to have only a minor role in pleasure perception. Two hypothesized states of prefrontal cortex activity driven by D1 and D2 pathway activity have been proposed; one D1 driven state in which there is a barrier allowing for high level of focus, and one D2 driven allowing for task switching with a weak barrier allowing more information in.

These models of the basal ganglia are thought to be relevant to the study of ADHD, Tourette syndrome, Parkinson's disease, schizophrenia, OCD, and addiction. For example, Parkinson's disease is hypothesized to be a result of excessive inhibitory pathway activity, which explains the slow movement and cognitive deficits, while Tourettes is proposed to be a result of excessive excitatory activity resulting in the tics characteristic of Tourettes.


Phasic Firing

The dopaminergic neurons in this circuit increase the magnitude of phasic firing in response to positive reward error, that is when the reward exceeds the expected reward. These neurons do not decrease phasic firing during a negative reward prediction (less reward than expected), leading to hypothesis that serotonergic, rather than dopaminergic neurons encode reward loss (source?). Dopamine phasic activity also increases during cues that signal negative events, however dopaminergic neuron stimulation still induces place preference, indicating its main role in evaluating a positive stimulus.From these findings, two hypotheses have developed, as to the role of the basal ganglia and nigrostiatal dopamine circuits in action selection. The first model suggests a "critic" which encodes value, and an actor which encodes responses to stimuli based on perceived value. However, the second model proposes that the actions do not originate in the basal ganglia, and instead originate in the cortex and are selected by the basal ganglia. This model proposes that the direct pathway controls appropriate behavior and the indirect suppresses actions not suitable for the situation. This model proposes that tonic dopaminergic firing increases the activity of the direct pathway, causing a bias towards executing actions faster.

References[edit]

  1. ^ a b "Beyond the Reward Pathway". Archived from the original on 2010-02-09. Retrieved 2009-10-23.
  2. ^ a b Le Moal, Michel. "Mesocorticolimbic Dopaminergic Neurons". Neuropsychopharmacology: The Fifth Generation of Progress. Archived from the original on 5 February 2018. Retrieved 4 November 2013.
  3. ^ Neuroscience. Dale Purves (5th ed ed.). Sunderland, Mass. 2012. ISBN 978-0-87893-695-3. OCLC 754389847. {{cite book}}: |edition= has extra text (help)CS1 maint: location missing publisher (link) CS1 maint: others (link)
  4. ^ Alcaro, Antonio; Huber, Robert; Panksepp, Jaak (24 January 2017). "Behavioral Functions of the Mesolimbic Dopaminergic System: an Affective Neuroethological Perspective". Brain Research Reviews. 56 (2): 283–321. doi:10.1016/j.brainresrev.2007.07.014. ISSN 0165-0173. PMC 2238694. PMID 17905440.
  5. ^ Galvan, Adriana; Wichmann, Thomas (24 January 2017). "Pathophysiology of Parkinsonism". Clinical Neurophysiology. 119 (7): 1459–1474. doi:10.1016/j.clinph.2008.03.017. ISSN 1388-2457. PMC 2467461. PMID 18467168.
  6. ^ Blum, Kenneth; Chen, Amanda Lih-Chuan; Braverman, Eric R; Comings, David E; Chen, Thomas JH; Arcuri, Vanessa; Blum, Seth H; Downs, Bernard W; Waite, Roger L; Notaro, Alison; Lubar, Joel; Williams, Lonna; Prihoda, Thomas J; Palomo, Tomas; Oscar-Berman, Marlene (24 January 2017). "Attention-deficit-hyperactivity disorder and reward deficiency syndrome". Neuropsychiatric Disease and Treatment. 4 (5): 893–918. doi:10.2147/NDT.S2627. ISSN 1176-6328. PMC 2626918. PMID 19183781.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  7. ^ Volkow, Nora D.; Wang, Gene-Jack; Fowler, Joanna S.; Tomasi, Dardo; Telang, Frank; Baler, Ruben (24 January 2017). "Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit". BioEssays. 32 (9): 748–755. doi:10.1002/bies.201000042. ISSN 0265-9247. PMC 2948245. PMID 20730946.
  8. ^ Guo Shiyi, Huang Jinsha, Jiang Haiyang, Han Chao, Li Jie, Xu Xiaoyun, Zhang Guoxin, Lin Zhicheng, Xiong Nian, Wang Tao (2017). "Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management". Front. Aging Neurosci. 9: 171. doi:10.3389/fnagi.2017.00171. PMC 5454050. PMID 28626420.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)